Phyla

📍 San Francisco, United States👥 31 employees💰 Last funded 2023
Biotechnology Research🌐 phyla.com
Website LinkedIn
At Phyla, we use cutting edge microbiome research and bacteriophage technology to develop new approaches to acne and other chronic diseases, providing long-term solutions without side effects. We leverage the microbiome and tackle the root cause, bacterial overgrowth, without causing collateral damage. Our products are clinically proven to kill only the bad bacteria, improve acne, and recalibrate the microbiome for long-term skin health. Additionally, our bacteriophage platform presents capabilities that can tackle many other bacterial diseases.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Phyla?
Phyla has 2 investors on record on gritt.io.
When did Phyla last raise funding?
The most recent investment in Phyla recorded on gritt.io was in 2023.
What industry is Phyla in?
Phyla operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Phyla based?
Phyla is headquartered in San Francisco, United States.